Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 2
1990 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Separan AP-273 and renal function: a novel natriuretic substance.
Smyth DD, Blandford DE, Jones DR, Polimeni PI. Smyth DD, et al. Can J Physiol Pharmacol. 1987 Sep;65(9):2001-3. doi: 10.1139/y87-313. Can J Physiol Pharmacol. 1987. PMID: 3690413
Recent studies have demonstrated that an anionic polyacrylamide (Separan, Union Carbide Corp.) decreased the formation of atherosclerotic lesions in the rabbit (Separan AP-30) and increased cardiac output (Separan AP-273) in the rat. ...
Recent studies have demonstrated that an anionic polyacrylamide (Separan, Union Carbide Corp.) decreased the formation of atherosclerotic le …
Protection against atherogenesis with the polymer drag-reducing agent Separan AP-30.
Faruqui FI, Otten MD, Polimeni PI. Faruqui FI, et al. Circulation. 1987 Mar;75(3):627-35. doi: 10.1161/01.cir.75.3.627. Circulation. 1987. PMID: 3815772
The inhibitory effect of Separan AP-30, an anionic polyacrylamide, on atherosclerotic plaque formation in aortas of rabbits on a high (2%) cholesterol diet was tested over a period extending from 37 to 170 days. ...
The inhibitory effect of Separan AP-30, an anionic polyacrylamide, on atherosclerotic plaque formation in aortas of rab …
Drag-reducing polymers: a novel class of diuretic and natriuretic compounds.
Smyth DD, Polimeni PI. Smyth DD, et al. Cardiovasc Drugs Ther. 1990 Feb;4(1):297-300. doi: 10.1007/BF01857648. Cardiovasc Drugs Ther. 1990. PMID: 2285623
Previous studies have demonstrated that Separan AP-30, a drag-reducing polymer, significantly decreased the formation of atherosclerotic plaques in rabbits fed a high-cholesterol diet. Furthermore, Separan AP-273, a polymer similar to but longer than Separ …
Previous studies have demonstrated that Separan AP-30, a drag-reducing polymer, significantly decreased the formation o …
Enhancement of aortic blood flow with a linear anionic macropolymer of extraordinary molecular length.
Polimeni PI, Ottenbreit B, Coleman P. Polimeni PI, et al. J Mol Cell Cardiol. 1985 Jul;17(7):721-4. doi: 10.1016/s0022-2828(85)80072-9. J Mol Cell Cardiol. 1985. PMID: 4020886
Mostardi et al. demonstrated with hot film anemometry that aortic flow instabilities downstream from a temporary partial occlusion are dampened after infusion of a polymer drag-reducing agent, Separan AP-30 (Dow Chemical Co.).(ABSTRACT TRUNCATED AT 250 WORDS) …
Mostardi et al. demonstrated with hot film anemometry that aortic flow instabilities downstream from a temporary partial occlusion are dampe …